| Elizabeth Ann Mckinney, ATC, LAT | |
|
618 8th St, Baldwin City, KS 66006-6009 | |
| (785) 594-8424 | |
| Not Available |
| Full Name | Elizabeth Ann Mckinney |
|---|---|
| Gender | Female |
| Speciality | Specialist/technologist - Athletic Trainer |
| Location | 618 8th St, Baldwin City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821504812 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Ann Mckinney, ATC, LAT Po Box 65, Baldwin City, KS 66006-0065 Ph: (785) 594-8424 | Elizabeth Ann Mckinney, ATC, LAT 618 8th St, Baldwin City, KS 66006-6009 Ph: (785) 594-8424 |
News Archive
Droplets emanating from a molecular "nano-tap" would behave very differently from those from a household tap 1 million times larger - researchers at the University of Warwick have found.
BELLUS Health announced today that it will discontinue its NC-503 diabetes development program following the results of the recently completed Phase IIa clinical proof-of-concept study evaluating NC-503 (eprodisate disodium) as a treatment for Type 2 diabetes. The study did not meet its primary efficacy endpoint.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
MIT neuroscientists have discovered that an enzyme called HDAC1 is critical for repairing age-related DNA damage to genes involved in memory and other cognitive functions.
› Verified 8 days ago